Skip to main content

Table 2 Model validation parameters

From: In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line

Parameter Model 1 Benchmarka
Friedman LOF 0.2006  
R-squared (R2) 0.7397 ≥ 0.6
Adjusted R-squared (R2adj.) 0.6712 ≥ 0.6
Cross validated R-squared (Q2cv) 0.5547 ≥ 0.5
Significant regression? Yes Yes
External validation (R2ext.) 0.7202 ≥ 0.6
  1. Key: a[31]